News

The US drug regulator has completed a pre-approval inspection at Emcure’s Ahmedabad oncology facility without issuing a Form ...
Emcure Pharma share price rose in trade after the company announced that United States Food and Drug Administration (USFDA) ...
For a pharmaceutical company, a clean FDA inspection report is crucial for maintaining and expanding its presence in global markets ...
Pune: Emcure Pharma has announced that the United States Food and Drug Administration (USFDA) has concluded a Pre-Approval ...
The US FDA had conducted Pre-Approval Inspection of Emcure Pharmaceuticals Limited's manufacturing facility (Oncology) located at G.I.D.C., Taluka - Sanand, Ahmedabad - 382110, Gujarat, from June 30, ...
June 26: 35 red points; 0 blue points. A pan of chicken tenders measured 95 degrees after being left unattended and without ...
Emcure Pharmaceuticals advanced 1.25% to Rs 1,271.85 after U.S. Food and Drug Administration (USFDA) conducted pre-approval inspection (PAI) at its manufacturing facility (Oncology) located at G.I.D.C ...
But for migrant farm ­workers, the extreme ­summer heat plagues them from their place of work into their employer-provided ...
The Kenya Bureau of Standards (Kebs) wants a case challenging a lucrative tender for inspection of goods before leaving the ...
Enhance FDA compliance with our expanded training on inspection processes, common issues, and strategies for prevention. Gain insights into Form 483 and warning letter prevention, root cause analysis, ...
FDA issued Complete Response Letter Capricor plans to resubmit its BLA to include data from the ongoing Phase 3 HOPE-3 trial ...
Capricor Therapeutics (CAPR) on Friday said the U.S. Food and Drug Administration (FDA) has refused to approve its lead cell ...